
Overview
Dentsply Sirona appoints Daniel Scavilla as CEO, effective August 1, 2025
Company reports preliminary Q2 2025 revenue of $935 mln, beating expectations
Adjusted EPS for Q2 2025 expected between $0.50 and $0.52
Outlook
Company reaffirms 2025 outlook from May 8 earnings release
Dentsply Sirona expects Q2 2025 net sales of $935 mln
Company anticipates Q2 2025 adjusted EPS between $0.50 and $0.52
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Preliminary revenue | Beat | $935 mln | $933.10 mln (13 Analysts) |
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 14 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."
Wall Street's median 12-month price target for DENTSPLY SIRONA Inc is $17.00, about 7.8% above its July 18 closing price of $15.68
The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 8 three months ago
Press Release: ID:nGNX8BX9zy